[ALNY] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock

[ALNY] Alnylam Pharmaceuticals, Inc.

Announcement Date

01-Aug-2024

Financial Year

2024

Quarter

30-Jun-2024 [#Q2]

Profit Trend

QoQ- 74.39%

YoY- 93.88%

Quarter Report

Filling Detail

Form 10-Q

ALNY's Result

ALNY's Financial Summary

View:

Show?

YoY %

Horiz. %

	30/06/24	30/06/23	30/06/22	30/06/21	30/06/20	30/06/19	30/06/18	CAGR
Quarter Result
Revenue	659,825	318,754	224,818	220,553	103,962	44,714	29,907	67.39%
YoY %	107.00%	41.78%	1.93%	112.15%	132.50%	49.51%	-	-
Horiz. %	2,206.26%	1,065.82%	751.72%	737.46%	347.62%	149.51%	100.00%	-
PBT	-11,167	-274,209	-274,673	-188,331	-177,903	-218,521	-163,481	-36.03%
YoY %	95.93%	0.17%	-45.85%	-5.86%	18.59%	-33.67%	-	-
Horiz. %	6.83%	167.73%	168.02%	115.20%	108.82%	133.67%	100.00%	-
Tax	5,722	1,815	2,729	1,228	1,326	960	79	104.03%
YoY %	215.26%	-33.49%	122.23%	-7.39%	38.12%	1,115.19%	-	-
Horiz. %	7,243.04%	2,297.47%	3,454.43%	1,554.43%	1,678.48%	1,215.19%	100.00%	-
NP	-16,889	-276,024	-277,402	-189,559	-179,229	-219,481	-163,560	-31.48%
YoY %	93.88%	0.50%	-46.34%	-5.76%	18.34%	-34.19%	-	-
Horiz. %	10.33%	168.76%	169.60%	115.90%	109.58%	134.19%	100.00%	-
Tax Rate	-	-	-	-	-	-	-	-
YoY %	-	-	-	-	-	-	-	-
Horiz. %	-	-	-	-	-	-	-	-
Total Cost	676,714	594,778	502,220	410,112	283,191	264,195	193,467	23.18%
YoY %	13.78%	18.43%	22.46%	44.82%	7.19%	36.56%	-	-
Horiz. %	349.78%	307.43%	259.59%	211.98%	146.38%	136.56%	100.00%	-

	30/06/24	30/06/23	30/06/22	30/06/21	30/06/20	30/06/19	30/06/18	CAGR
Ratio Analysis
NP Margin	-2.56	-86.59	-123.39	-85.95	-172.40	-490.86	-546.90	-59.06%
YoY %	97.04%	29.82%	-43.56%	50.15%	64.88%	10.25%	-	-
Horiz. %	0.47%	15.83%	22.56%	15.72%	31.52%	89.75%	100.00%	-

	30/06/24	30/06/23	30/06/22	30/06/21	30/06/20	30/06/19	30/06/18	CAGR
Per Share
EPS	-0.13	-2.21	-2.29	-1.61	-1.56	-2.02	-1.63	-34.36%
YoY %	94.12%	3.49%	-42.24%	-3.21%	22.77%	-23.93%	-	-
Horiz. %	7.98%	135.58%	140.49%	98.77%	95.71%	123.93%	100.00%	-
EPS Diluted	-0.13	-2.21	-2.29	-1.61	-1.56	-2.02	-1.63	-34.36%
YoY %	94.12%	3.49%	-42.24%	-3.21%	22.77%	-23.93%	-	-
Horiz. %	7.98%	135.58%	140.49%	98.77%	95.71%	123.93%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.

Latest Videos

MQ Market Updates - 27 September 2024

MQ Trader

Apps

MQ Chat

Send individual or group chats with anyone on i3investor

MQ Trader

Earn MQ Points while trading with MQ Trader

MQ Affiliate

Earn side income from Affiliate Program

MQdemy

Online learning and teaching marketplace

Hot Stocks Today >

NVDA

NVIDIA Corporation

1000

ONCO

Onconetix, Inc.

952

AAPL

Apple Inc.

952

BABA

Alibaba Group Holding Limited

857

PLTR

Palantir Technologies Inc.

809

MSFT

Microsoft Corporation

809

AGN

714

IONQ

IonQ, Inc.

476

SOXL

Direxion Daily Semiconductor Bull 3X Shares

476

CHD

Church & Dwight Co., Inc.

476

Daily Stocks

SLNA

0.03

-0.008

379,091,456

CYXT

0.065

0.00

369,807,727

NVDA

121.35

-2.69

261,440,344

XPON

0.072

+0.008

254,700,571

UWT

0.164

-0.002

244,137,454

CNEY

0.96

+0.38

221,012,173

AGIL

0.197

+0.114

206,404,986

TNXP

0.146

+0.009

205,191,089

LYLT

0.218

0.00

204,480,452

ZNGA

8.18

-0.17

184,885,916

More active Stocks

BRK-A

686,182.40

+2,842.43

1,167

NVR

9,734.55

+174.58

12,487

RTLA

209.90

+74.87

WHLRL

148.50

+47.50

2,290

ACSG

33.28

+33.28

99,050

EMSA

140.77

+30.77

EMLB

80.80

+30.30

NOVVU

41.00

+28.85

17,976

NOVV

37.00

+23.46

205,220

EDTX

63.24

+20.01

603,885

More gainer Stocks

MELI

1,629.32

-188.66

1,851,535

MSTR

1,309.00

-138.99

2,237,917

MKL

1,395.13

-102.30

318,280

MPWR

838.63

-96.05

902,546

LOWC

30.18

-92.412

1,236,074

NOW

643.29

-87.83

5,025,012

NVDA

762.00

-84.71

85,558,284

MEDP

357.30

-79.88

1,004,401

MDB

236.06

-73.94

10,812,930

MCK

547.51

-70.00

4,067,959

More loser Stocks

Books Review >

Ride The Bull Short The Bear

CS Tan

4.9 / 5.0

This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....

Read More